Skip to content
中文产业新闻精选评分67Chinese source

正大天晴HER2双抗ADC TQB2102治疗HER2低表达乳腺癌三期临床达到主要终点

正大天晴HER2双抗ADC低表达乳腺癌Ⅲ期临床达到预期

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.